These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 20343817)

  • 1. Clotting defect in hemophilia; deficiency in a plasma factor required for thromboplastin liberation from platelets.
    BRINKHOUS KM
    Fed Proc; 1947; 6(1):389. PubMed ID: 20343817
    [No Abstract]   [Full Text] [Related]  

  • 2. [Test of generation of hematic thromboplastin in stage I. II. Results in some coagulation diseases].
    CIOFFI LA; LAVITRANO R
    Boll Soc Ital Biol Sper; 1961 Dec; 37():1304-6. PubMed ID: 13879572
    [No Abstract]   [Full Text] [Related]  

  • 3. The relation of certain fractions of the plasma globulins to the coagulation defect in hemophilia.
    LEWIS JH; TAGNON HJ
    Blood; 1946 Mar; 1():166-72. PubMed ID: 21015979
    [No Abstract]   [Full Text] [Related]  

  • 4. Interaction of convertin with platelets and with platelet-free and hemophilic plasma.
    DE VRIES A; KREJNIS E; SHAFRIR E
    Acta Haematol; 1956 Sep; 16(3):204-13. PubMed ID: 13354260
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of incubation on the anthemophilic globulin of adsorbed plasma and of adsorbed plasma-serum mixture. Absence of true consumption of the anthemophilic globulin and of development of a thromboplastin-accelerator power].
    MAYER G; MAYER S
    C R Seances Soc Biol Fil; 1961; 155():653-6. PubMed ID: 14471691
    [No Abstract]   [Full Text] [Related]  

  • 6. Clotting defect in hemophilia; deficiency in a plasma factor required for platelet utilization.
    BRINKHOUS KM
    Proc Soc Exp Biol Med; 1947 Oct; 66(1):117-20. PubMed ID: 20270694
    [No Abstract]   [Full Text] [Related]  

  • 7. [The consumption of antihemophilic globulin and the development of thromboplastin accelerator power in the adsorbed plasma-recalcified serum mixture. The problem of the responsible serum substrate].
    MAYER G; MAYER S; WAITZ R
    Rev Fr Etud Clin Biol; 1961 Nov; 6():924-8. PubMed ID: 14471688
    [No Abstract]   [Full Text] [Related]  

  • 8. Clotting of hemophilic blood with purified platelet cofactor I, platelet factor 3 and threone.
    SEEGERS WH; LANDABURU RH; HOLBURN RR; TOCANTINS LM
    Proc Soc Exp Biol Med; 1957 Jul; 95(3):583-5. PubMed ID: 13453515
    [No Abstract]   [Full Text] [Related]  

  • 9. [Influence of temperature on blood coagulation in vitro (author's transl)].
    Dreher A; Sutor AH
    Blut; 1978 Apr; 36(4):231-8. PubMed ID: 306264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Coagulation factors and blood platelets. (Presence and location of factor VIII and of fibrinogen in normal human platelets and in patients with coagulation disorders, using an immunofluorescence technic)].
    Fabris F; Betterle C; Casonato A; De Marco L; Girolami A
    Ric Clin Lab; 1979; 9(2 Suppl):51-63. PubMed ID: 395621
    [No Abstract]   [Full Text] [Related]  

  • 11. Prothrombin utilization following addition of platelet confactor I concentrates to hemophilic plasma.
    JOHNSON JF; MAMMEN EF; SEEGERS WH
    Thromb Diath Haemorrh; 1959 Sep; 3():588-92. PubMed ID: 14407473
    [No Abstract]   [Full Text] [Related]  

  • 12. The coagulation activity of incomplete thromboplastins and bridge anticoagulant.
    PUDLAK P; DEIMLOVA E; STARA I
    Br J Haematol; 1959 Oct; 5():413-20. PubMed ID: 14435243
    [No Abstract]   [Full Text] [Related]  

  • 13. [The so-called antithromboplastin (ogen)emias].
    Pelick E; von Knorre G; Bergmann A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 94(3):209-13. PubMed ID: 4100724
    [No Abstract]   [Full Text] [Related]  

  • 14. [Study of the blood of ten hemophiliacs by the inactivated thromboplastin method].
    GOUTTAS A; TSEVRENIS H; ROMBOS C; FESSAS P; CARALI
    Acta Haematol; 1954 Sep; 12(3):203-8. PubMed ID: 13196937
    [No Abstract]   [Full Text] [Related]  

  • 15. [Capacity of activation of so-called deficient factors in hereditary blood coagulation disorders].
    Mingers AM
    Fortschr Med; 1976 Oct; 94(30):1723-5. PubMed ID: 1086815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHRISTMAS disease.
    Br Med J; 1952 Dec; 2(4799):1405-6. PubMed ID: 12997803
    [No Abstract]   [Full Text] [Related]  

  • 17. CLOTTING IN HEPARINISED PLASMA. II. UNDERLYING REACTIONS.
    FANTL P
    Aust J Exp Biol Med Sci; 1965 Feb; 43():45-64. PubMed ID: 14269280
    [No Abstract]   [Full Text] [Related]  

  • 18. Concurrent hemophilia and qualitative platelet disturbance.
    DJERASSI I; DE VRIES A; FISHER I; REMEZ D
    Acta Haematol; 1957 Nov; 18(5):354-8. PubMed ID: 13487188
    [No Abstract]   [Full Text] [Related]  

  • 19. [Method of study of the thromboplastin-accelerator power and of the antithemophilic globulin consumption of the 1st intermediary products].
    MAYER G; MAYER S; WAITZ R
    Rev Fr Etud Clin Biol; 1961 Mar; 6():301-3. PubMed ID: 13768565
    [No Abstract]   [Full Text] [Related]  

  • 20. Christmas disease: a condition previously mistaken for haemophilia.
    BIGGS R; DOUGLAS AS; MACFARLANE RG; DACIE JV; PITNEY WR; MERSKEY
    Br Med J; 1952 Dec; 2(4799):1378-82. PubMed ID: 12997790
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.